Clinical trial
Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis…
NCT00361894 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00361894 |
|---|---|
| Title | Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement. |
| Official title | RECORD 3 Study: REgulation of Coagulation in ORthopedic Surgery to Prevent DVT and PE; a Controlled., Double-blind, Randomized Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement. |
| Acronym | RECORD 3 |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prevention, Venous Thromboembolism |
| Intervention type | Drug |
| Interventions | Rivaroxaban (BAY59-7939), Enoxaparin |
| Enrollment | 2,531 |
| Start date | Feb 1, 2006 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Aug 9, 2006 |
| Last update posted | Oct 27, 2014 |
| Countries | Austria, Belgium, Canada, China, Colombia, Czechia, Denmark, France, Germany, Israel, Italy, Mexico and 7 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: